Mural Oncology plc – Filings and Transcripts – BamSEC

You must log in to view this page.

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

Prospectuses and Registrations Filter

Securities registration termination

Removal from listing

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Ownership Filter

Trium Capital LLP

Hickey Benjamin

Jackson Scott Thomas

News Filter

Announces Effectiveness of Scheme of Arrangement and Completion of Acquisition

Shareholder Vote Results, Other Events

Announces Entry Into Agreement to Be Acquired by XRA 5 Corp., a Wholly Owned Subsidiary of XOMA Royalty for Between $2.035 and $2.24 in Cash Per Share

Continues to Explore Strategic Alternatives Estimates Cash and Cash Equivalents of Approximately $43 to $48 Million at December 31, 2025, if It Has Not Consummated a Transaction or Other Strategic Alternative by Year End

Shareholder Vote Results

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC